Sarepta (SRPT) Trades Higher on Eteplirsen Phase II Update, Analyst Comments
Go back to Sarepta (SRPT) Trades Higher on Eteplirsen Phase II Update, Analyst Comments| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 52.41 +0.45 (0.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.96 | 52 Week High | $45.58 | |||
| Open | $51.35 | 52 Week Low | $37.82 | |||
| Day High | $52.57 | P/E | N/A | |||
| Day Low | $51.35 | EPS | $0.00 | |||
| Volume | 2,404,769 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 18.79 -0.43 (2.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.22 | 52 Week High | $63.73 | |||
| Open | $19.39 | 52 Week Low | $8.00 | |||
| Day High | $19.73 | P/E | N/A | |||
| Day Low | $18.66 | EPS | $-5.69 | |||
| Volume | 1,674,598 | |||||
